Startseite Evaluation of the Innovance D-DIMER analytical performance
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Evaluation of the Innovance D-DIMER analytical performance

  • Desiree Coen Herak , Marija Milos und Renata Zadro
Veröffentlicht/Copyright: 24. Juni 2009
Veröffentlichen auch Sie bei De Gruyter Brill

Abstract

Background: Widespread use of D-dimer in recent years has led to the development of a number of new fully automated quantitative D-dimer assays.

Methods: We evaluated the analytical performance of the particle-enhanced immunoturbidimetric assay Innovance D-DIMER (Siemens Medical Solutions) on the Behring Coagulation System (BCS) analyzer.

Results: Within-run coefficients of variation (CVs) for samples with low, borderline, slightly, and extremely increased D-dimer concentrations were 2.1%–5.5%, whereas between-run CVs for control samples with low and extremely increased D-dimer were 5.5%–8.4%. The assay exhibited good linearity in the working range between 0.17 mg/L and 5.45 mg/L fibrinogen equivalent units (FEU), with the lower limit of detection of 0.099 mg/L FEU. The upper reference value determined in 40 plasma samples from healthy volunteers was 0.495 mg/L FEU. The results obtained in 457 fresh plasma samples were compared with results obtained with VIDAS D-Dimer Exclusion. Passing and Bablok regression analysis demonstrated highly significant correlation (y=1.370x–0.108, r=0.952, p<0.001). Bland and Altman difference plots demonstrated slightly higher results obtained with Innovance D-DIMER that was more pronounced with increasing values. Very good agreement between both assays was observed (κ=0.860; 95% confidence interval (CI), 0.811–0.908).

Conclusions: This study demonstrates that Innovance D-DIMER fulfills all analytical requirements for daily routine use.

Clin Chem Lab Med 2009;47:945–51.


Corresponding author: Renata Zadro, Clinical Institute of Laboratory Diagnosis, Zagreb University School of Medicine and Clinical Hospital Center, Zagreb, Croatia Phone: +38512367360, Fax: +38512367395,

Received: 2009-2-23
Accepted: 2009-5-7
Published Online: 2009-06-24
Published in Print: 2009-08-01

©2009 by Walter de Gruyter Berlin New York

Artikel in diesem Heft

  1. Editorial
  2. Hemolysis index: quality indicator or criterion for sample rejection?
  3. Review
  4. Neutrophil CD64: a diagnostic marker for infection and sepsis
  5. Genetics and Molecular Diagnostics
  6. Chromosome 9p21 polymorphism is associated with myocardial infarction but not with clinical outcome in Han Chinese
  7. Differential expression of microRNAs in the placentae of Chinese patients with severe pre-eclampsia
  8. Clinical, biochemical, and genetic analysis of a Korean neonate with hereditary tyrosinemia type 1
  9. General Clinical Chemistry and Laboratory Medicine
  10. Multicenter evaluation of the hemolysis index in automated clinical chemistry systems
  11. Haemolysis index – an estimate of preanalytical quality in primary health care
  12. Evaluation of the Innovance D-DIMER analytical performance
  13. Heterophile antibodies may falsely increase or decrease thyroglobulin measurement in patients with differentiated thyroid carcinoma
  14. Variation of barrier permeability for albumin and immunoglobulin G influx into cerebrospinal fluid
  15. Anti-citrullinated protein antibody and rheumatoid factor in patients with end-stage renal disease
  16. Reference Values and Biological Variations
  17. Quality of interpretative commenting on common clinical chemistry results in the Asia-Pacific region and Africa
  18. Analysis and interpretation of drug testing results from patients on chronic pain therapy: a clinical laboratory perspective
  19. Cancer Diagnostics
  20. HER1-4 protein concentrations in normal breast tissue from breast cancer patients are expressed by the same profile as in the malignant tissue
  21. Comparison of fifteen immunoassays for the measurement of serum MUC-1/CA 15-3 in breast cancer patients
  22. Serum levels of matrix metalloproteinase-2 and -9 and conventional tumor markers (CEA and CA 19-9) in patients with colorectal and gastric cancers
  23. Unstimulated high sensitive thyroglobulin measurement predicts outcome of differentiated thyroid carcinoma
  24. Relationship of serum antioxidant micronutrients and sociodemographic factors to cervical neoplasia: a case-control study
  25. Letters to the Editor
  26. Clinical efficacy of two cardiac troponin I assays
  27. Impeded centrifugation in plasmocytoma serum
Heruntergeladen am 23.10.2025 von https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2009.219/html
Button zum nach oben scrollen